Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial CancerMcConkey, David J ; Choi, Woonyoung ; Shen, Yu ; Lee, I.-Ling ; Porten, Sima ; Matin, Surena F ; Kamat, Ashish M ; Corn, Paul ; Millikan, Randall E ; Dinney, Colin ; Czerniak, Bogdan ; Siefker-Radtke, Arlene OEuropean urology, 2016-05, Vol.69 (5), p.855-862 [Periódico revisado por pares]Switzerland: Elsevier B.VTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Targeting the interleukin-11 receptor a in metastatic prostate cancer a first-in-man studyRenata Pasqualini Randall E Millikan; Dawn R Christianson; Marina Cardó-Vila; Wouter H. P Driessen; Ricardo José Giordano; Amin Hajitou; Anh G Hoang; Sijin Wen; Kirstin F Barnhart; Wallace B Baze; Valerie D Marcott; David H Hawke; Kim-Anh Do; Nora M Navone; Eleni Efstathiou; Patricia Troncoso; Roy R Lobb; Christopher J Logothetis; Wadih ArapCancer Hoboken v. 121, n. 14, p. 2411-2421, 2015Hoboken 2015Item não circula. Consulte sua biblioteca.(Acessar) |
3 |
Material Type: Artigo
|
![]() |
Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate CancerAPARICIO, Ana M ; HARZSTARK, Andrea L ; TANNIR, Nizar M ; ZURITA, Amado J ; MATHEW, Paul ; ARAP, Wadih ; TRONCOSO, Patricia ; THALL, Peter F ; LOGOTHETIS, Christopher J ; CORN, Paul G ; SIJIN WEN ; ARAUJO, John C ; TU, Shi-Ming ; PAGLIARO, Lance C ; KIM, Jeri ; MILLIKAN, Randall E ; RYAN, CharlesClinical cancer research, 2013-07, Vol.19 (13), p.3621-3630 [Periódico revisado por pares]Philadelphia, PA: American Association for Cancer ResearchTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Neoadjuvant Chemotherapy in Small Cell Urothelial Cancer Improves Pathologic Downstaging and Long-term Outcomes: Results from a Retrospective Study at the MD Anderson Cancer CenterLynch, Siobhan P ; Shen, Yu ; Kamat, Ashish ; Grossman, H. Barton ; Shah, Jay B ; Millikan, Randall E ; Dinney, Colin P ; Siefker-Radtke, ArleneEuropean urology, 2013-08, Vol.64 (2), p.307-313 [Periódico revisado por pares]Kidlington: Elsevier B.VTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Refining Patient Selection for Neoadjuvant Chemotherapy before Radical CystectomyCulp, Stephen H ; Dickstein, Rian J ; Grossman, H. Barton ; Pretzsch, Shanna M ; Porten, Sima ; Daneshmand, Siamak ; Cai, Jie ; Groshen, Susan ; Siefker-Radtke, Arlene ; Millikan, Randall E ; Czerniak, Bogdan ; Navai, Neema ; Wszolek, Matthew F ; Kamat, Ashish M ; Dinney, Colin P.NThe Journal of urology, 2014-01, Vol.191 (1), p.40-47 [Periódico revisado por pares]New York, NY: Elsevier IncTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Plasmacytoid Urothelial Carcinoma, a Chemosensitive Cancer with Poor Prognosis, and Peritoneal CarcinomatosisDayyani, Farshid ; Czerniak, Bogdan A ; Sircar, Kanishka ; Munsell, Mark F ; Millikan, Randall E ; Dinney, Colin P ; Siefker-Radtke, Arlene OThe Journal of urology, 2013-05, Vol.189 (5), p.1656-1661 [Periódico revisado por pares]New York, NY: Elsevier IncTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Evaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced Prostate CancerWang, Lu ; Rotnitzky, Andrea ; Lin, Xihong ; Millikan, Randall E ; Thall, Peter FJournal of the American Statistical Association, 2012-06, Vol.107 (498), p.493-508 [Periódico revisado por pares]United States: Taylor & Francis GroupTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Reply from Authors re: Camillo Porta. How to Identify Active Novel Agents in Rare Cancers and then Make Them Available: A Need for a Paradigm Shift. Eur Urol 2012;62:1020–1Tannir, Nizar M ; Thall, Peter ; Millikan, Randall EEuropean urology, 2012-12, Vol.62 (6), p.1022-1022 [Periódico revisado por pares]Texto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Phase II Presurgical Feasibility Study of Bevacizumab in Untreated Patients With Metastatic Renal Cell CarcinomaJONASCH, Eric ; WOOD, Christopher G ; ARAUJO, John C ; ARAP, Wadih ; TANNIR, Nizar ; MATIN, Surena F ; TU, Shi-Ming ; PAGLIARO, Lance C ; CORN, Paul G ; APARICIO, Ana ; TAMBOLI, Pheroze ; MILLIKAN, Randall E ; XUEMEI WANGJournal of clinical oncology, 2009-09, Vol.27 (25), p.4076-4081 [Periódico revisado por pares]Alexandria, VA: American Society of Clinical OncologyTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
A Phase l Study of a Tumor-targeted Systemic Nanodelivery System, SGT-94, in Genitourinary CancersSiefker-Radtke, Arlene ; Zhang, Xin-qiao ; Guo, Charles C ; Shen, Yu ; Pirollo, Kathleen F ; Sabir, Sharjeel ; Leung, Chris ; Leong-Wu, Cindy ; Ling, Chi-Ming ; Chang, Esther H ; Millikan, Randall E ; Benedict, William FMolecular therapy, 2016-08, Vol.24 (8), p.1484-1491 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |